首页|表达Strep-tag Ⅱ的重组塞内卡病毒的构建与鉴定

表达Strep-tag Ⅱ的重组塞内卡病毒的构建与鉴定

Construction and identification of recombinant Senecavirus expressing Strep-tag Ⅱ

扫码查看
为构建表达Strep-tag Ⅱ的重组塞内卡病毒(SVA),本研究在感染性cDNA克隆pSVA-I212V/S460L的基础上,采用重叠延伸PCR扩增Strep-tag Ⅱ并采用无缝克隆法将其插入SVA VP1基因C端,构建感染性cDNA克隆,命名为pSVA-Strep,并采用双酶切和测序鉴定正确后,将pSVA-Strep转染BHK-21细胞拯救重组病毒,收集病变细胞上清,并将含有病毒的细胞上清和野生型SVA(SVA-WT)分别感染BHK-21细胞,以未感染病毒的BHK-21细胞作为阴性对照,感染后24 h分别以鼠源SVA VP2蛋白单克隆抗体(MAb)5D10(1∶1 000)、鼠源Strep-tag Ⅱ MAb(1∶2 000)作为一抗,以FITC标记的山羊抗小鼠IgG(1∶2 000)为二抗,采用间接免疫荧光试验(IFA)对重组病毒鉴定.IFA结果显示,以鼠源SVA VP2蛋白MAb 5D10为一抗,SVA-WT和重组病毒感染的细胞均出现绿色荧光,以Strep-tag Ⅱ MAb作为一抗时,仅有重组病毒感染的细胞出现绿色荧光,经SVA-WT感染的BHK-21细胞及阴性对照细胞均无绿色荧光,表明拯救了Strep-tag Ⅱ标记的重组病毒,并将其命名为rSVA-Strep.将rSVA-Strep在BHK-21细胞中连续传10代,每隔2代采用引物VP1-F/R经PCR鉴定并对第10代重组病毒的VP1基因测序以鉴定rSVA-Strep的遗传稳定性.结果显示,每隔两代的重组病毒经PCR扩增后均出现约780 bp的目的条带,第10代重组病毒扩增的VP1基因测序结果显示Strep-tag Ⅱ基因仍在重组病毒中,且无基因突变,表明rSVA-Strep的遗传稳定性较强;将SVA-WT和rSVA-Strep分别以MOI 0.01感染BHK-21细胞,在感染后4 h、8 h、12 h、24 h、36 h、48 h和72 h收获病毒测定病毒滴度并绘制生长曲线,结果显示在病毒感染36 h内rSVA-Strep和SVA-WT生长动力学基本一致,表明Strep-tag Ⅱ的引入在病毒感染36 h内对SVA的复制基本无影响.采用0.2%甲醛充分灭活rSVA-Strep,并利用Strep-Tactin® XT Purification纯化试剂盒纯化该灭活病毒,将rSVA-Strep灭活病毒上清加至Strep-Tactin亲和层析柱,分别用不同体积洗脱缓冲液依次洗脱病毒并通过western blot鉴定病毒的纯化效果.对纯化过程中不同洗脱液洗脱病毒的western blot结果显示,不同体积的洗脱液中E1、E2和E3均出现VP0和VP2两条带,且E1和E2的条带最明显,表明洗脱缓冲液的最佳洗脱体积约为2.2 CV;以上结果表明rSVA-Strep可通过Strep-Tactin亲和层析柱一步法纯化.本研究在SVA中插入Strep-tag Ⅱ标签,为SVA灭活疫苗的快速纯化提供技术手段,也为其他病原的快速纯化方法的建立提供参考.
In order to construct Senecavirus A expressing Strep-tag Ⅱ,Strep-tag Ⅱ was inserted into the C-terminus of the VP1 gene of SVA-I212V/S460L infective clone by overlapping extended PCR method.The reconstructed infectious clone was then transfected into BHK-21 cells to rescue the recombinant virus,and the supernatant was collected after CPE was detected.BHK-21 cells were infected with the virus supernatant and wild type SVA,respectively,and the BHK-21 cells without virus infection were used as negative control.Cells infected with recombinant virus were identified 24 hours after infection by indirect immunofluorescence assas(IFA),mouse anti-SVA VP2 protein MAb 5D10 and mouse anti-Strep-tag Ⅱ MAb were used as primary antibodies,respectively.IFA results exhibited that both SVA-WT and rSVA-Strep infected cells showed specific fluorescence signals when mouse anti-SVA VP2 protein MAb 5D10 was used as the primary antibody,while only recombinant virus infected cells showed specific fluorescence signals when anti-Strep-tag Ⅱ MAb was used as the primary antibody.None of the negative controls showed a special fluorescent signal,indicating that the Strep-tag Ⅱ-labeled recombinant virus was successfully rescued and named rSVA-Strep.To determine the genetic stability of rSVA-Strep,the recombinant virus was passaged in BHK-21 cells for 10 continuously generations.The recombinant virus gene was amplified with primer VP1-F/VP1-R every 2 generations,and the amplified gene of the 10th generation was sequenced.The result displayed that the target bands of about 780bp were present in all the amplified recombinant virus genes,and no mutantion was detected in Strep-tag Ⅱ gene of the 10th generation,indicating that Strep-tag Ⅱ gene was stable in rSVA-Strep replication.BHK-21 cells were infected with either SVA-WT or rSVA-Strep with a multiplicity of infection(MOI)of 0.01,and the virus were harvested at 4 hours,8 hours,12 hours,24 hours,36 hours,48 hours and 72 hours after infection and the virus titer was determined.The results showed that the growth curve of rSVA-Strep and SVA-WT were basically consistent within 36 hours of viral infection,indicating that the insertion of Strep-tag Ⅱ had no obvious effect on the replication of SVA.rSVA-Strep was fully inactivated by 0.2%formaldehyde,and the inactivated virus was purified by Strep-Tactin® XT Purification kit.The inactivated rSVA-Strep was added to Strep-Tactin affinity chromatographic column,the column was then washed by different volumes of elution buffer to elute the virus.And the purification efficiency was evaluated by western blot.The results showed that VP0 and VP2 bands appeared in E1,E2 and E3,among which E1 and E2 showed the most obvious bands,demonstrating that the optimal elution volume was about 2.2 CV.These results indicate that the Strep-tag Ⅱ on the C-terminal of capsid protein VP1 specifically binds to the Strep-Tactin column,which is conducive to the rapid purification of SVA antigens.In this study,Strep-tag Ⅱ tag was successfully inserted into SVA,which can provide technical means for the rapid purification of SVA inactivated vaccine,and also provide reference for the establishment of rapid purification methods for other pathogens.

SenecavirusStrep-tag Ⅱinfectious cloneantigen purification

史家宝、蒙靓、肖培宇、范峻豪、安同庆、王海伟、于力

展开 >

中国农业科学院哈尔滨兽医研究所 动物疫病防控全国重点实验室,黑龙江 哈尔滨 150069

塞内卡病毒 Strep-tag 感染性克隆 抗原纯化

黑龙江省重点研发计划

JD22A023

2024

中国预防兽医学报
中国农业科学院哈尔滨兽医研究所

中国预防兽医学报

CSTPCD北大核心
影响因子:0.674
ISSN:1008-0589
年,卷(期):2024.46(2)
  • 19